Clinical Laserthermia Systems AB
Develops image-guided laser ablation systems for urology and neurosurgery applications.
CLS | ST
Overview
Corporate Details
- ISIN(s):
- SE0022049912 (+3 more)
- LEI:
- 549300TH4O6D9205O691
- Country:
- Sweden
- Address:
- Scheelevägen 2, 223 81 Lund
- Website:
- https://clinicallaser.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
Clinical Laserthermia Systems (CLS) is a medical technology company that develops and markets advanced systems for minimally invasive, high-precision laser ablation of diseased tissue. Its flagship product, the TRANBERG® Thermal Therapy System, is an integrated platform designed for image-guided treatments with real-time monitoring and control. The company's technology is primarily applied in urology for the focal therapy of localized prostate cancer and in neurosurgery for treating brain tumors and epileptogenic foci. CLS's solutions aim to improve patient outcomes by targeting lesions precisely, sparing healthy tissue, and reducing side effects, enabling faster patient recovery. The company also advances immune-stimulating ablation techniques to enhance anti-cancer responses.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Clinical Laserthermia Systems AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Clinical Laserthermia Systems AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Clinical Laserthermia Systems AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-23 | Hans von Celsing | Other | Sell | 4,000 | 15,200.00 SEK |
Peer Companies
